[Warning: growing number of young-adults with gonorrhea].

Ned Tijdschr Geneeskd

RIVM, Bilthoven. Centrum Infectieziektebestrijding (CIb).

Published: March 2025

Since 2022, an steeply increase has been seen in the number of gonorrhea infections in the Netherlands: in 2023 in the sexual heath centra 31% more cases were found, especially among groups where this is less obvious, such as high educated young women. Gonorrhea infections can be seen with the classic symptoms of an urethritis (the drip). But also asymptomatic or in more severe ways and in different locations. In this clinical lesson we provide 3 examples of gonorrhea infections in young women. In neighboring countries, increasing resistance is being observed for ceftriaxone, the first-choice antibiotic to treat gonorrhea. For adequate treatment and to break the infection chain complete microbiological diagnostics or a test of cure can be necessary. The article ends with prevention measures: condom use and effective partner notification.

Download full-text PDF

Source

Publication Analysis

Top Keywords

gonorrhea infections
12
young women
8
[warning growing
4
growing number
4
number young-adults
4
young-adults gonorrhea]
4
gonorrhea] 2022
4
2022 steeply
4
steeply increase
4
increase number
4

Similar Publications

Identification of novel inhibitors targeting serine acetyltransferase from Neisseria gonorrhoeae.

Comput Struct Biotechnol J

February 2025

School of Pharmacy and Biomedical Science, University of Waikato, Hamilton 3216, New Zealand.

is an obligate human pathogen and the etiological agent of the sexually transmitted infection, gonorrhoea. The rapid emergence of extensively antimicrobial-resistant strains, including those resistant to all frontline antibiotics, has led to being labelled a priority pathogen by the World Health Organization, highlighting the need for new antimicrobial treatments. Given its absence in humans, targeting cysteine biosynthesis has been identified as a promising avenue for developing new antimicrobials against bacterial pathogens.

View Article and Find Full Text PDF

Doxy-PEP is used to prevent chlamydia, syphilis and gonorrhea infections in sexual and gender minority men and transgender women. We describe a systematic process for developing algorithms that allow for the identification of doxy-PEP prescriptions. Using an identified algorithm will allow for improved monitoring of implementation and effectiveness.

View Article and Find Full Text PDF

[Warning: growing number of young-adults with gonorrhea].

Ned Tijdschr Geneeskd

March 2025

RIVM, Bilthoven. Centrum Infectieziektebestrijding (CIb).

Since 2022, an steeply increase has been seen in the number of gonorrhea infections in the Netherlands: in 2023 in the sexual heath centra 31% more cases were found, especially among groups where this is less obvious, such as high educated young women. Gonorrhea infections can be seen with the classic symptoms of an urethritis (the drip). But also asymptomatic or in more severe ways and in different locations.

View Article and Find Full Text PDF

Objectives: Describe the clinical, phenotypic and genomic characteristics of ceftriaxone-resistant from Scotland.

Methods: Cases were identified in routine care from 2018 to 2024. Minimum inhibitory concentrations were determined for seven antimicrobial agents.

View Article and Find Full Text PDF

Objective: Pelvic inflammatory disease (PID) is an infection of female reproductive organs mainly in sexually active patients, which can cause serious complications throughout life. We aimed to analyze the risk factors and differences in sexually transmitted infections (STIs) between adolescents and adult PID patients.

Materials And Methods: We conducted a retrospective study based on descriptive and statistical analyses of the clinical records of patients with PID treated with antibiotics between January 2013 and December 2023 at Busan Paik Hospital.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!